List of drugs used to treat the medical condition called Ankylosing Spondylitis. Click on the drug to find more information including the brand names,dose,side-effects, adverse events, when to take the drug and the price of the drug.
Generic and Trade Names of Drugs for Treatment of Ankylosing Spondylitis
Aceclofenac is a nonsteroidal anti-inflammatory drug (NSAID), prescribed for fever, pain, ankylosing spondylitis and arthritis. It blocks the action of a substance in the body (cyclo-oxygenase), which may cause pain, swelling and inflammation.
Adalimumab is a tumor necrosis factor alpha (TNF alpha) inhibitor, prescribed for rheumatoid arthritis, crohn's disease (digestive tract inflammation), psoriatic arthritis, ulcerative colitis, plaque psoriasis, ankylosing spondylitis (spine infammation), and juvenile idiopathic arthritis (joint inflammation in children). It blocks the effect of TNF and thereby reduces the inflammation and its consequences in the joints and intestine.
Flurbiprofen is a non-steroidal anti-inflammatory agent (NSAIA), prescribed for pain, tenderness, swelling, and stiffness caused by osteoarthritis (arthritis caused by a breakdown of the lining of the joints) and rheumatoid arthritis (arthritis caused by swelling of the lining of the joints), inflammation of eye, dysmenorrhea. It prevents the production of irritant chemicals that cause pain, fever, and inflammation.
Meloxicam is a non-steroidal anti-inflammatory agent (NSAIA), prescribed for pain, swelling, and stiffness caused by breakdown of joints. It is also used in children 2 years of age and older for juvenile rheumatoid arthritis (a type of arthritis that affects children). It prevents the production of certain chemicals that cause pain and inflammation in the body.
Prednisone regulates the symptoms of low corticosteroid levels, and is used to treat arthritis, severe allergic reactions, multiple sclerosis, lupus, and certain conditions that affect the lungs, skin, eyes, kidneys blood, thyroid, stomach, and intestines.
Secukinumab is a recombinant human monoclonal antibody which is used in the treatment of moderate-to-severe plaque psoriasis (a type of skin disease with red and scaly patches in parts of the body), and active ankylosing spondylitis and psoriatic arthritis. It blocks the action of interleukin-17A and thereby reduces inflammation.
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer